Geometry.Net - Health_Conditions: Eosinophilia

Eosinophilia
Professionals only. eosinophilia,, Print this article, refers to an increaseof the number of eosinophils within the peripheral blood. It
http://www.amershamhealth.com/medcyclopaedia/Volume V 1/EOSINOPHILIA.asp
Tropical Eosinophilia
Tropical eosinophilia,, Print this article, a filariasis). Wuschereriabancrofti is the most common cause of tropical eosinophilia.
http://www.amershamhealth.com/medcyclopaedia/Volume V 1/tropical eosinophilia.ht

Extractions: *For Medical Professionals only, registration required Tropical eosinophilia, a syndrome consisting of cough, wheezing and severe blood eosinophilia due to a parasitic infection by a filarial worm (filariasis). Wuschereria bancrofti is the most common cause of tropical eosinophilia. The chest radiograph may be normal but usually shows widespread fine nodular or reticulonodular opacities . Occasionally, localized consolidation is present. The radiological changes usually resolve with treatment. Sometimes, resolution takes months, and rarely interstitial pulmonary fibrosis may occur.
Faith Rumph's Story: Eosinophilia-Myalgia Syndrome
Faith Rumph eosinophiliaMyalgia Syndrome. eosinophilia and myalgia weresymptoms of the new disease, and I had all the markers of it.
http://www.sclero.org/support/stories/submissions/faith-rumph/a-to-z.html

Extractions: The International Scleroderma Network (ISN) Now Available in 18 Languages: Bahasa Malaysia Chinese Deutsche (German) English ... Worldwide Support Groups Stories by Type and by Date BY TYPE OF STORY: Calcinosis Caregivers Survivors: In Memory Of CREST Syndrome Difficult Diagnosis and Undiagnosed Diffuse Scleroderma Eosinophilic Fasciitis Fibromyalgia Interstitial Cystitis Kidney (Renal) Stories Lichen Sclerosus Limited Scleroderma Linear Scleroderma Morphea Scleroderma Overlap Syndrome Pulmonary Fibrosis Pulmonary Hypertension Pulmonary: Lung Transplant Raynaud's Scleredema Adultorum Buschke Skeletal Involvement Carpal Tunnel Joint Contractures Rotator Cuff Telangiectasia Thyroid Disease Watermelon Stomach STORIES ON OTHER SITES BY DATE POSTED 1999 Stories 2000 Stories 2001 Stories 2002 Stories Jan 2002 Feb 2002 Mar 2002 Apr 2002 May 2002 Jun 2002 Jul 2002 Aug 2002 Sep 2002 Oct 2002 Nov 2002 Dec 2002 Jan-Mar 2003 BY LANGUAGE English (main page) French Greek Italian Polish Romanian Russian Spanish How to Submit Your Story Story Tip Sheet Story Submission Form French Stories
ThinkQuest Library Of Entries
eosinophilia eosinophilia is the exact opposite of lymphocytopia where there is anoverproduction in the number of white blood cells present in the bloodstream
http://library.thinkquest.org/C0115080/?c=eosinophilia&v=printable
ThinkQuest Library Of Entries
eosinophilia eosinophilia is the exact opposite of lymphocytopia where there is anoverproduction in the number of white blood cells present in the bloodstream
http://library.thinkquest.org/C0115080/?c=eosinophilia
Eosinophilia
of these people. eosinophilia is a part of the Rain Collective ScanGallery Dolls and Playthings Wallpaper Nick Nacks Sitely Book.
http://novacaine.net/eosin/

Extractions: heyo, Welcome to Rain's overgrown goodies page ^_^ This site serves to satisfy my terrible need to scan almost everytime I get a new artbook ^^;;; Beware the scanaholic that is Senka. I have various bits and pieces here, ranging from Artbook scans and wallpaper to paper dollies and sheet music. Feel free to browse. The shortened do.nu addy comes courtesy of these people. Eosinophilia is a part of the Rain Collective Scan Gallery Dolls and Playthings
Case 7 (with Eosinophilia)
Case 7 (with eosinophilia). Click the image to see a more detailed version.Case 7 (with eosinophilia). Bone marrow smear, MayGiemsa stain, x1000.
http://pathy.med.nagoya-u.ac.jp/atlas/doc/node33.html
FDA/CFSAN "Dear Colleague" Letter On L-Tryptophan And Eosinophilia-Myalgia Syndr
US Food and Drug Administration Office of Health Affairs January 17, 1990. Dear Colleague letter on LTryptophan and eosinophilia-Myalgia Syndrome.
http://vm.cfsan.fda.gov/~dms/ds-ltr1.html

Extractions: L-Tryptophan and Eosinophilia-Myalgia Syndrome Dear Colleague: We are writing to provide you with important information about a strong association between the consumption of L-tryptophan and a cluster of symptoms called Eosinophilia-Myalgia Syndrome (EMS). Analysis by the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) of case reports received over recent months has shown a virtually unequivocal link between the consumption of L-tryptophan tablets or capsules and EMS. FDA has, therefore, instituted a nationwide recall of all over-the-counter dietary supplements in capsule or tablet form providing for 100 milligrams (mg) or more of L-tryptophan in a daily dose. Dietary supplements providing for less than 100 mg. will remain on the market pending further evaluation. As explained below, the scientific explanation for the risk with L-tryptophan use is not yet fully understood, but we believe it is important to communicate to you what is currently know. Physicians and other health professionals may also find useful our background information on EMS symptoms and on the regulatory status of L-tryptophan products at this time. We will inform you of any major changes in these matters as they occur. Background As of January 12, 1990, state health departments had reported 1,070 EMS cases to CDC. In at least one case, a patient with L-tryptophan-induced EMS died of an ascending polyneuropathy. L-tryptophan-induced EMS may have played a role in six other deaths; this is under investigation.
FDA/CFSAN "Dear Colleague" Letter Regarding The Research On Eosinophilia-Myalgia
Dear Colleague letter regarding the Research on eosinophiliaMyalgia Syndromeand Current Regulatory Status of L-Tryptophan. Dear Colleague
http://vm.cfsan.fda.gov/~dms/ds-ltr3.html

Extractions: Current Regulatory Status of L-Tryptophan Dear Colleague: LT Recall and Import Alert Our first letter regarding this subject, dated January 17, 1990, identified the association between LT consumption and EMS and advised you of the recall of capsules and tablets providing 100 milligrams of LT or greater. On February 2, 1990, FDA notified you regarding an expansion of the recall to include all dietary supplements containing "manufactured, added" LT. On March 22, 1990, FDA also imposed an Important Alert prohibiting the importation of manufactured LT, which included all forms in bulk, and LT as a single ingredient or major ingredient of tablets, capsules, caplets, liquids or powders into the United States without prior FDA approval. An exception is provided for LT used for special dietary purposes (see page 4). Because all of the LT sold in the U.S. was produced elsewhere, the net effect of the recall and Import Alert has been a ban on most oral dosage forms of LT. Health professionals should be aware that although LT is not on the U.S. market, FDA and CDC have confirmed reports within the past year of persons who have become ill after consuming LT obtained through illegal means. LT as a Component of "Health Foods" FDA has received numerous reports from consumers concerned that LT is still on the market in the form of "sports" formulas, weight gain products and protein supplements. Many of these products display the amino acid content on the label in an amino acid profile. FDA has investigated these reports and invariably found the source of LT, as well as other amino acids, to be intact animal or plant proteins which may or may not be hydrolyzed to free amino acids. LT typically comprises about 1.6% of the total weight of amino acids in these products. No case of EMS has definitively been associated with any of these products, although several are under investigation.
Update: Eosinophilia-Myalgia Syndrome Associated With Ingestion Of L-Tryptophan
Update eosinophiliaMyalgia Syndrome Associated with Ingestion ofL-Tryptophan United States, through August 24, 1990. As of
http://www.cdc.gov/mmwr/preview/mmwrhtml/00001738.htm

Extractions: As of August 24, 1990, 1536 cases of eosinophilia-myalgia syndrome (EMS) had been reported to CDC from all 50 states, the District of Columbia, and Puerto Rico (Figure 1) (1-5). Twenty-seven deaths have been reported in patients who met the surveillance case definition and who used L-tryptophan-containing products (LTCPs). As of August 24, CDC had received 1117 completed report forms from state and territorial health departments. Ages of patients ranged from 4 years to 85 years (median: 48 years); 1046 (94%) of the patients were non-Hispanic white, 19 (2%) were Hispanic, 12 (1%) were black, and 40 (4%) were from other or unknown racial/ethnic groups; and 930 (83%) were female. One thousand sixty-eight (96%) patients had histories of LTCP ingestion preceeding onset of symptoms. Symptom onset during or after July 1989 was reported in 946 (85%). Eight (0.7%) patients had onset on or after February 1, 1990. Three hundred sixty (32%) patients had been hospitalized for their illnesses by the time the cases were reported. Reported by: State and territorial health departments. Div of Environmental Hazards and Health Effects, Center for Environmental Health and Injury Control, CDC. Editorial Note: On November 17, 1989, the Food and Drug Administration (FDA) recalled all dietary supplements that provided a daily dose of L-tryptophan (LT) greater than or equal to 100 mg. By March 22, 1990, this recall had been expanded to include all LTCPs at any dosage except some protein supplements, infant formulas and special dietary foods, and intravenous and oral solutions in which small amounts of LT are needed for nutrient fortification.
Current Trends Eosinophilia-Myalgia Syndrome: Follow-up Survey Of Patients --- N
Current Trends eosinophiliaMyalgia Syndrome Follow-up Survey ofPatients - New York, 1990 - 1991. As of December 1, 1990, 151
http://www.cdc.gov/mmwr/preview/mmwrhtml/00014514.htm

Extractions: As of December 1, 1990, 151 cases of eosinophilia-myalgia syndrome (EMS)* had been reported to the New York State Department of Health (NYSDOH); 10 of these patients died. Of the 151 case-patients, 149 were known to have used supplemental L-tryptophan (LT) before onset of illness. Because anecdotal reports indicated that some patients in New York had changes in mental status and other symptoms not previously described in association with EMS, the NYSDOH conducted a survey from December 1990 through March 1991 to determine the prevalence of self-reported symptoms in patients with EMS. A detailed questionnaire was sent by the NYSDOH to all living patients, asking them to report on the presence of 47 specific symptoms at any time during their illness and at the time of the survey. For each symptom, severity was reported as minimal, moderate, or extreme. Of the 139 living case-patients who had used LT before onset of EMS, 91 (65%) completed the questionnaire a median of 16 months after onset of illness (range: 1140 months). The median age of respondents was 51 years (range: 3284 years); 78% were women. Thirty-seven (41%) had been hospitalized at least once following onset of symptoms. Patients who completed and who did not complete the questionnaire were similar in age, sex, and peak eosinophil count.
Tropical Eosinophilia
Publications. Tropical eosinophilia. Tropical eosinophilia is associated with markedincreases in total serum IgE, and antibodies to filaria are of high titer.
http://www.trc-chennai.org/Publications/pub351.htm

Extractions: Publications Tropical eosinophilia Spry Christopher, J.F.; Kumaraswami, V. Seminars in Haemotology; 1982; 19; 107-115 Tropical eosinophilia is a systematic disease consisting predominantly of respiratory symptoms, malaise, fever, and weight loss with a marked increase in blood eosinophil counts of over 3 x 10 /Litre. it occurs in children and adults in areas of endemic filariasis, including the Indian subcontinent, South-East Asia, and South Pacific Islands, but imported cases in temperate climates are being recognised with increasing frequency. There is a spectrum of clinical disease, ranging from asymptomatic eosinophilia to a severe chronic constitutional illness with asthmatic episodes and densities in chest radiographs. The importance of the respiratory component in tropical eosinophilia is illustrated by other names for the disease, which include eosinophilic lung and tropical pulmonary eosinophilia. Tropical eosinophilia is associated with marked increases in total serum IgE, and antibodies to filaria are of high titer. Several observations have shown that the disease is a hyper-sensitivity reaction to microfilariae. It has been produced by self-inoculation sequentially with
CMRRC Eosinophilia-Myalgia Syndrome Publications
eosinophiliaMyalgia Syndrome Neurologic, MR imaging, and MR spectroscopicfindings in the eosinophilia-Myalgia Syndrome . Haseler
http://cnid.unm.edu/publications/ems.html

Extractions: Results: Neurologic findings that were increased in CNS-EMS included minor depression (100%; p 0.05). Self reported disability was markedly increased in CNS-EMS (p <0.0001). MRI findings included subcortical focal lesions, focal lesions in deep white matter, cortical atrophy, ventricular dilatation, and diffuse and periventricular white matter abnormalities (p
Eosinophilic Fasciitis & Eosinophilia-Myalgia Syndrome
Feature article on eosinophilic fasciitis and eosinophiliamyalgia syndrome,dated 6/2/02. Eosinophilic Fasciitis eosinophilia-Myalgia Syndrome.
http://rarediseases.about.com/library/weekly/aa060202a.htm

Extractions: Disorders similar but not the same Join the Discussion "My daughter was diagnosed with EF 6 years ago. . . . This is a very painful disease and causes the person to have a very limited life style. We have desperately tried to find any doctor(s) who are the least familiar with EF and may know of a treatment that will help her. If there is anyone reading this who can help, please let us know. She is only 26, is now housebound with the exception of dr visits and deserves a chance at a normal life. Thank you."
NATIONAL EOSINOPHILIA-MYALGIA SYNDROME NETWORK
CLICK HERE TO ENTER SITE NEMSN, EMS, eosinophiliaMyalgia Syndrome, Showa Denko,Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement
http://216.247.115.236/nemsn/

Extractions: CLICK HERE TO ENTER SITE CLICK HERE TO ENTER SITE NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP NEMSN, EMS, Eosinophilia-Myalgia Syndrome, Showa Denko, Tryptophan, L-Tryptophan, Blood Disease, Contaminated Vitamin Supplement, Epidemic, Peak-E, CDC Banned, FMS (fibromyalgia syndrome), Dietary Supplements, Auto-immune Disorders, Health Foods, Toxic Oil Syndrome (TOS), Muscular Diseases, New Diseases, FDA Enforcement, Amino Acid Supplements, Amino Acids, Biotechnology, Melatonin, 5-HTP
Health Information Resource Database: National Eosinophilia-Myalgia Syndrome Net
National eosinophiliaMyalgia Syndrome Network, Inc. Contact Information. 141Dunbar St. Abstract. National eosinophilia-Myalgia Syndrome Network, Inc.
http://www.health.gov/nhic/NHICScripts/Entry.cfm?HRCode=HR2933
Member Sign In
Laboratory Tests for Physician Assistants Ask The Expert What Might Causeeosinophilia in a Young Woman? from Medscape Primary Care Question.
http://www.medscape.com/viewarticle/413583
Member Sign In
Pleural Fluid and Serum eosinophilia from Southern Medical Journal. Discussion. Physiologyof pleural fluid eosinophilia is not clearly established.
http://www.medscape.com/viewarticle/410571_3
Angiolymphoid Hyperplasia With Eosinophilia
Angiolymphoid Hyperplasia with eosinophilia. Image URL Angiolymphoid hyperplasiawith eosinophilia, Image URL Angiolymphoid hyperplasia with eosinophilia,
http://www.brisbio.ac.uk/ROADS/subject-listing/angiolymphoidhyperplasiawitheosin
Angiolymphoid Hyperplasia With Eosinophilia
PATHOGENESIS, CHARACTERIZATION. GENERAL, Angiolymphoid hyperplasia with eosinophilia. Wereport a case of angiolymphoid hyperplasia with eosinophilia (ALHE).
http://www.thedoctorsdoctor.com/diseases2/alhe.htm

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

41-60 of 90 Back | 1 | 2 | 3 | 4 | 5 | Next 20